Progress in the Clinical Use of 3-(Ortho-Toloxy)-1, 2-Propanediol (Mephenesin) in Neurologic Disorders
- 30 March 1950
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 242 (13), 502-507
- https://doi.org/10.1056/nejm195003302421304
Abstract
THE distress of many motor disorders is produced by exaggerated stretch reflexes (spasticity), excessive resistance to passive movement (rigidity) or abnormal involuntary movement of central origin (hyperkinesia).To be satisfactory, a therapeutic agent must be easy to administer, preferably orally, effective in prolonged administration and devoid of untoward side effects. Specifically, it should depress abnormal motor activity without impairing consciousness, coordination or normal motor functions. Numerous agents used on this service and elsewhere have failed in one or more respects. Parpanit,1 Prostigmine and intravenous injection of procaine have been ineffective. Though the belladonna alkaloids have been helpful in selected cases . . .This publication has 28 references indexed in Scilit:
- EFFECTS OF MYANESIN UPON THE CENTRAL NERVOUS SYSTEMThe American Journal of the Medical Sciences, 1949
- MYANESINAnaesthesia, 1948
- MYANESIN IN TETANUSThe Lancet, 1948
- Metabolism of α : β-Dihydroxy-γ-(2-methyl-phenoxy)propane (‘Myanesin')Nature, 1948
- "Myanesin" as a Relaxant in ChildrenBMJ, 1948
- MYANESIN AS AN AID TO ANÆSTHESIA IN CHILDRENThe Lancet, 1948
- MYANESINAnaesthesia, 1948
- EFFECTS OF MYANESIN ON MUSCLES AND BLOODThe Lancet, 1948
- Myanesin as a Muscle Relaxant.*Anesthesia & Analgesia, 1948
- HqMOGLOBINURIA AFTER INTRAVENOUS MYANESINThe Lancet, 1947